Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • HAEMONETICS CORP Financial Overview

  • Income Statement: HAE
      2009 2008 Change ( 2008 - 2009  )
    Net Sales/Revenues 597.88 M 516.44 M 81.44 M 13.62%
    Gross Profit 308.17 M 257.72 M 50.44 M 16.37%
    Net Income Before Extra Items/Preferred Div 59.30 M 51.98 M 7.32 M 12.35%
    Operating Income 85.57 M 70.29 M 15.28 M 17.86%
    View Full Report

  • Cash Flow: HAE
      2009 2008 Change ( 2008 - 2009  )
    Net Cash Flow - Financing -30.74 M -73.23 M 42.49 M -138.24%
    Net Cash Flow - Investing 60.00 M 102.85 M -42.85 M -71.41%
    Net Cash Flow/Operating Activities 116.36 M 77.67 M 38.70 M 33.25%
    View Full Report

  • Balance Sheet: HAE

      2009 2008 Change ( 2008 - 2009  )
    Total Assets 646.69 M 599.71 M 46.98 M 7.26%
    Total Liabilities 106.80 M 105.52 M 1.28 M 1.20%
    Shareholders Equity 539.88 M 494.19 M 45.70 M 8.46%
    View Full Report

  • Key Ratios / Statistics: HAE

    • Valuation

      Price/Earnings (TTM) 25.00
      Price/Sales (TTM) 2.93
      Price/Book (MRQ) 2.61
      Price/Cash Flow (TTM) 12.38

    • Profitability

      Gross Margin 51.54
      Operating Margin 14.31
      Profit Margin 9.92

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 2.95
      Current Ratio (MRQ) 3.60
      Long Term Debt-to-Equity (MRQ) 0.86

    • Management Effectiveness

      Return on Equity (TTM) 11.97
      Return on Assets (TTM) 10.21
      Return on Investments (TTM) 11.28
    View All Key Ratios